LBT Innovations
|
|||||
BackgroundIn 1881, Robert Koch, one of the founding fathers of microbiology, first described a technique for isolating and examining bacterial colonies using pools of gelatine-based media on glass slides.Read More |
ProductsLBT Innovations' first license partner is French diagnostics giant bioMérieux to commercialise MicroStreak®.Read More |
Live Share PriceASX:LBTLast trade: A$0.05 Trade time: 4:10PM GMT+10 Value change: 0.00% More Information |
NewsletterClick below to subscribe |